Results 121 to 130 of about 54,678 (274)

Baseline maximum standardised uptake value does not predict outcomes in high‐tumour‐burden follicular lymphoma treated with first‐line immunochemotherapy

open access: yesBritish Journal of Haematology, EarlyView.
Baseline maximum standardised uptake value does not predict survival in high‐tumour‐burden follicular lymphoma treated with first‐line immunochemotherapy, but identifies patients at risk of histological transformation: no transformation occurred below the cohort median. Its role is to guide biopsy and surveillance rather than therapeutic stratification.
Ikram Bouguern   +10 more
wiley   +1 more source

NRF1 predominantly causes EZH2 overexpression in cancer cells

open access: yesCell Death and Disease
EZH2 is an oncogene and therapeutic target. Only a small proportion of cancer patients benefit from treatment with EZH2 inhibitors (EZH2is). The mechanisms underlying EZH2 overexpression and EZH2i resistance are not clear.
Juanli Qiao   +3 more
doaj   +1 more source

Long non‐coding RNAs at the crossroads of inflammation, cancer and angiogenesis: Molecular mechanisms and their potential as therapeutic targets

open access: yesBritish Journal of Pharmacology, EarlyView.
Long non‐coding RNAs (lncRNAs), a broad class of non‐protein‐coding RNAs, are characterized as new regulators of gene expression at the epigenetic, transcriptional, and post‐transcriptional level. Thus, lncRNAs are involved in the regulation of physiological processes and the development of human diseases and cancer by modulating proinflammatory ...
Charlie Leboff   +3 more
wiley   +1 more source

The roles of EZH2 in cell lineage commitment

open access: yes, 2012
[[abstract]]Enhancer of zeste homolog 2 (EZH2), a catalytic component of polycomb repressive complex 2 (PRC2), epigenetically regulates chromatin structure and gene expressions through tri-methylation at histone H3K27 and recruitment of DNA ...
鄒瑞煌;Chou, Ruey-Hwang;余永倫;Yu, Yung-luen;洪明奇;Hung, Mien-Chie
core  

Transcriptional repression of TIMP3 by EZH2 promotes invasion of prostate cancer cells.

open access: yes, 2012
(A) Western blot analysis of EZH2 and TIMP3 expression in RWPE-1 cells after an infection with the indicated combinations of lentivirus expressing EZH2, TIMP3 and control virus.
Yong Jae Shin (187976)   +1 more
core   +1 more source

WDR12 Promotes Glucose Metabolism via PFKFB4 Upregulation in Gastric Cancer

open access: yesCancer Science, EarlyView.
WDR12 promotes glucose metabolism and tumor growth in GC. Mechanistically, WDR12 interacts with TDP43 and appears to enhance PFKFB4 expression, thereby promoting glucose metabolism. ABSTRACT Metabolic reprogramming is a hallmark of gastric cancer (GC); however, the role of transcriptional regulators in modulating glycolysis remains incompletely ...
Rutong Zhang   +5 more
wiley   +1 more source

EZH2 Regulates Neuronal Differentiation of Human Mesenchymal Stem Cells through PIP5K1C-Dependent Calcium Signaling

open access: yes, 2010
[[abstract]]Enhancer of zeste homolog 2 (EZH2), a polycomb group (PcG) protein, regulates stem cells renewal and differentiation. Phosphatidylinositol-4-phosphate 5-kinase, type I gamma (PIP5K1C) plays an important role in synthesis of ...
Ling-Tzu Chen
core  

EZH2 represses ISGs directly and also activates them indirectly.

open access: yes, 2019
(A) Enrichment of biological processes among genes activated by EZH2, calculated by Enrichr. (B) Heat map showing differential expression of interferon-stimulated genes (ISGs) in response to EZH2 knockout.
Steven V. Le (7377995)   +2 more
core   +1 more source

The Role of IGF2BP3‐Mediated Immune Response Activation in Enhancing Immunotherapy of Koumine for Gastric Cancer

open access: yesCancer Science, EarlyView.
Koumine binds IGF2BP3 and promotes its proteasomal degradation, reducing m6A on EED mRNA, accelerating EED decay, lowering H3K27me3, and promoting IRF transcription, thereby restoring MHC‐I and enhancing CD8+ T cell killing. ABSTRACT Resistance to immune checkpoint blockade in gastric cancer often arises from defective antigen presentation due to MHC‐I
Qiu Hongqiang   +10 more
wiley   +1 more source

Treatment‐Free Remission in Chronic Myeloid Leukemia: Toward Precision and Personalized Approaches to Functional Cure

open access: yesCancer Science, EarlyView.
Immune surveillance of residual leukemic stem cells after tyrosine kinase inhibitor discontinuation involves coordinated NK‐cell, CTL, Treg, pDC, and neutrophil activity that predicts treatment‐free remission, while exhausted CTLs and Treg expansion predict relapse in chronic myeloid leukemia.
Hiroshi Ureshino, Shinya Kimura
wiley   +1 more source

Home - About - Disclaimer - Privacy